These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38008090)

  • 21. A single-center experience of post-transplant atypical hemolytic uremic syndrome.
    Abu Jawdeh BG; Khan MA
    Clin Nephrol; 2023 Aug; 100(2):75-81. PubMed ID: 37288831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An extremely rare splice site mutation in the gene encoding complement factor I in a patient with atypical hemolytic uremic syndrome.
    Ipe TS; Lim J; Reyes MA; Ero M; Leveque C; Lewis B; Kain J
    J Clin Apher; 2017 Dec; 32(6):584-588. PubMed ID: 28455885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Life-Threatening Extrarenal Manifestations in an Infant with Atypical Hemolytic Uremic Syndrome Caused by a Complement 3-Gene Mutation.
    Han SR; Cho MH; Moon JS; Ha IS; Cheong HI; Kang HG
    Kidney Blood Press Res; 2019; 44(5):1300-1305. PubMed ID: 31522186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of eculizumab and plasma exchange in successful combined liver-kidney transplantation in a case of atypical HUS associated with complement factor H mutation.
    Tran H; Chaudhuri A; Concepcion W; Grimm PC
    Pediatr Nephrol; 2014 Mar; 29(3):477-80. PubMed ID: 24221349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies.
    Phillips EH; Westwood JP; Brocklebank V; Wong EK; Tellez JO; Marchbank KJ; McGuckin S; Gale DP; Connolly J; Goodship TH; Kavanagh D; Scully MA
    J Thromb Haemost; 2016 Jan; 14(1):175-85. PubMed ID: 26559391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. De novo systemic atypical hemolytic uremic syndrome in an ABO-incompatible living kidney transplant recipient with a novel pathogenic CFHR1 gene mutation successfully treated with eculizumab: a case report.
    Li D; Wang W; Chen R; Wen J; Zhang M
    J Nephrol; 2022 Sep; 35(7):1895-1899. PubMed ID: 35852773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atypical hemolytic and uremic syndrome due to C3 mutation in pancreatic islet transplantation: a case report.
    Bahougne T; Olagne J; Munch M; Braun-Parvez L; Chenard MP; Frémeaux-Bacchi V; Caillard S; Baltzinger P; Greget M; Kessler L; Moulin B
    BMC Nephrol; 2020 Sep; 21(1):405. PubMed ID: 32950058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel Complement Factor B Gene Mutation Identified in a Kidney Transplant Recipient with a Shiga Toxin-Triggered Episode of Thrombotic Microangiopathy.
    Korzycka J; Pawłowicz-Szlarska E; Masajtis-Zagajewska A; Nowicki M
    Am J Case Rep; 2022 Oct; 23():e936565. PubMed ID: 36306276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Case report: Novel FHR2 variants in atypical Hemolytic Uremic Syndrome: A case study of a translational medicine approach in renal transplantation.
    Stea ED; Skerka C; Accetturo M; Pesce F; Wiech T; Hartman A; Pontrelli P; Conserva F; Castellano G; Zipfel PF; Gesualdo L
    Front Immunol; 2022; 13():1008294. PubMed ID: 36451836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ten-year outcome of Eculizumab in kidney transplant recipients with atypical hemolytic uremic syndrome- a single center experience.
    Kant S; Bhalla A; Alasfar S; Alachkar N
    BMC Nephrol; 2020 May; 21(1):189. PubMed ID: 32434487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eculizumab induces long-term remission in recurrent post-transplant HUS associated with C3 gene mutation.
    Al-Akash SI; Almond PS; Savell VH; Gharaybeh SI; Hogue C
    Pediatr Nephrol; 2011 Apr; 26(4):613-9. PubMed ID: 21125405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemolytic uremic syndrome with dual caution in an infant: cobalamin C defect and complement dysregulation successfully treated with eculizumab.
    Barlas UK; Kıhtır HS; Goknar N; Ersoy M; Akcay N; Sevketoglu E
    Pediatr Nephrol; 2018 Jun; 33(6):1093-1096. PubMed ID: 29558000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome.
    Cugno M; Gualtierotti R; Possenti I; Testa S; Tel F; Griffini S; Grovetti E; Tedeschi S; Salardi S; Cresseri D; Messa P; Ardissino G
    J Thromb Haemost; 2014 Sep; 12(9):1440-8. PubMed ID: 24853860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Midterm Outcomes of 12 Renal Transplant Recipients Treated With Eculizumab to Prevent Atypical Hemolytic Syndrome Recurrence.
    Levi C; Frémeaux-Bacchi V; Zuber J; Rabant M; Devriese M; Snanoudj R; Scemla A; Amrouche L; Mejean A; Legendre C; Sberro-Soussan R
    Transplantation; 2017 Dec; 101(12):2924-2930. PubMed ID: 28858176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peri- and Post-operative Evaluation and Management of Atypical Hemolytic Uremic Syndrome (aHUS) in Kidney Transplantation.
    Java A
    Adv Chronic Kidney Dis; 2020 Mar; 27(2):128-137. PubMed ID: 32553245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
    Frémeaux-Bacchi V; Fakhouri F; Roumenina L; Dragon-Durey MA; Loirat C
    Rev Med Interne; 2011 Apr; 32(4):232-40. PubMed ID: 21376430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adult Post-Kidney Transplant Familial Atypical Hemolytic Uremic Syndrome Successfully Treated With Eculizumab: A Case Report and Literature Review.
    Salameh H; Abu Omar M; Alhariri A; Kisra S; Qasem A; Abdulhak AB
    Am J Ther; 2016; 23(4):e1110-5. PubMed ID: 25486517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atypical Hemolytic Uremic Syndrome Occurring After Receipt of mRNA-1273 COVID-19 Vaccine Booster: A Case Report.
    Claes KJ; Geerts I; Lemahieu W; Wilmer A; Kuypers DRJ; Koshy P; Ombelet S
    Am J Kidney Dis; 2023 Mar; 81(3):364-367. PubMed ID: 36342000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and effectiveness of eculizumab for adult patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.
    Kato H; Miyakawa Y; Hidaka Y; Inoue N; Ito S; Kagami S; Kaname S; Matsumoto M; Mizuno M; Matsuda T; Shimono A; Maruyama S; Fujimura Y; Nangaku M; Okada H
    Clin Exp Nephrol; 2019 Jan; 23(1):65-75. PubMed ID: 29959568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of atypical hemolytic uremic syndrome in a second renal transplant.
    Zwang NA; Ho B; Kanwar YS; Lewis B; Cusick M; Friedewald JJ; Gallon L
    J Nephrol; 2018 Feb; 31(1):165-172. PubMed ID: 28224376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.